Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

MET amplification + MET Exon 14 mutation

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

MET amplification + MET Exon 14 mutation	Non Small Cell Lung Cancer	MET amplification + MET Exon 14 mutation	Non Small Cell Lung Cancer	crizotinib Sensitive: C2 – Inclusion Criteria crizotinib Sensitive : C2	crizotinib Sensitive: C2 – Inclusion Criteria crizotinib Sensitive : C2
MET amplification + MET Exon 14 mutation	Lung Adenocarcinoma	MET amplification + MET Exon 14 mutation	Lung Adenocarcinoma	savolitinib Sensitive: C4 – Case Studies savolitinib Sensitive : C4	savolitinib Sensitive: C4 – Case Studies savolitinib Sensitive : C4
MET amplification + MET Exon 14 mutation	Non Small Cell Lung Cancer	MET amplification + MET Exon 14 mutation	Non Small Cell Lung Cancer	cabozantinib tablet Sensitive: C4 – Case Studies cabozantinib tablet Sensitive : C4	cabozantinib tablet Sensitive: C4 – Case Studies cabozantinib tablet Sensitive : C4